XILAPLUS® AF:
The medical device is intended to restore the physiological functions of the intestinal walls,…
We are pleased to announce the launch of UTIPRO® PLUS AF in Portugal.
Portugal is the first European country in which UTIPRO® PLUS AF has been launched in its composition free from…
- Acquisition allows Noventure to maintain focus on medical devices and grow therapeutic areas in which it operates
- Medical devices contain Olea Europaea…
We are happy to inform that Utipro® Plus AF is ready to land in Central Asia thanks to its very recent registration in Kazakhstan.
All evidence supporting the product has been evaluated by…
New publication for Utipro® Plus
We are pleased to announce the publication of a case series referring about the benefits of Utipro® Plus in some challenging cases of urinary infections. In…